119 related articles for article (PubMed ID: 10484990)
1. Clinical and molecular features of Ewing sarcoma in a patient with triple-X syndrome.
Patiño-García A; López de Mesa R; de Alava E; Sierrasesúmaga L
Cancer Genet Cytogenet; 1999 Sep; 113(2):188-90. PubMed ID: 10484990
[TBL] [Abstract][Full Text] [Related]
2. EWS/FLI-1 fusion signal inserted into chromosome 11 in one patient with morphologic features of Ewing sarcoma, but lacking t(11;22).
Batanian JR; Bridge JA; Wickert R; Vogler C; Gadre B; Huang Y
Cancer Genet Cytogenet; 2002 Feb; 133(1):72-5. PubMed ID: 11890993
[TBL] [Abstract][Full Text] [Related]
3. Impact of EWS-ETS fusion type on disease progression in Ewing's sarcoma/peripheral primitive neuroectodermal tumor: prospective results from the cooperative Euro-E.W.I.N.G. 99 trial.
Le Deley MC; Delattre O; Schaefer KL; Burchill SA; Koehler G; Hogendoorn PC; Lion T; Poremba C; Marandet J; Ballet S; Pierron G; Brownhill SC; Nesslböck M; Ranft A; Dirksen U; Oberlin O; Lewis IJ; Craft AW; Jürgens H; Kovar H
J Clin Oncol; 2010 Apr; 28(12):1982-8. PubMed ID: 20308673
[TBL] [Abstract][Full Text] [Related]
4. Current treatment protocols have eliminated the prognostic advantage of type 1 fusions in Ewing sarcoma: a report from the Children's Oncology Group.
van Doorninck JA; Ji L; Schaub B; Shimada H; Wing MR; Krailo MD; Lessnick SL; Marina N; Triche TJ; Sposto R; Womer RB; Lawlor ER
J Clin Oncol; 2010 Apr; 28(12):1989-94. PubMed ID: 20308669
[TBL] [Abstract][Full Text] [Related]
5. Small interfering RNAs expressed from a Pol III promoter suppress the EWS/Fli-1 transcript in an Ewing sarcoma cell line.
Dohjima T; Lee NS; Li H; Ohno T; Rossi JJ
Mol Ther; 2003 Jun; 7(6):811-6. PubMed ID: 12788655
[TBL] [Abstract][Full Text] [Related]
6. Evidence of neural differentiation in a case of post-therapy primitive neuroectodermal tumor/Ewing sarcoma of bone.
Collini P; Mezzelani A; Modena P; Dagrada P; Tamborini E; Luksch R; Gronchi A; Navarria P; Sozzi G; Pilotti S
Am J Surg Pathol; 2003 Aug; 27(8):1161-6. PubMed ID: 12883251
[TBL] [Abstract][Full Text] [Related]
7. Primary Hepatic Ewing Sarcoma With EWS-FLI1 RNA Transcript in a Child.
Pochon C; Martelli H; Mussini C; Pariente D; Heymann MF; Corradini N
J Pediatr Hematol Oncol; 2015 Jul; 37(5):411-3. PubMed ID: 25411865
[No Abstract] [Full Text] [Related]
8. Synthetic siRNA targeting the breakpoint of EWS/Fli-1 inhibits growth of Ewing sarcoma xenografts in a mouse model.
Takigami I; Ohno T; Kitade Y; Hara A; Nagano A; Kawai G; Saitou M; Matsuhashi A; Yamada K; Shimizu K
Int J Cancer; 2011 Jan; 128(1):216-26. PubMed ID: 20648560
[TBL] [Abstract][Full Text] [Related]
9. Translocation of chromosomes 11 and 22 in choroidal metastatic Ewing sarcoma detected by fluorescent in situ hybridization.
Chan CC; Pack S; Pak E; Tsogos M; Zhuang Z
Am J Ophthalmol; 1999 Feb; 127(2):226-8. PubMed ID: 10030577
[TBL] [Abstract][Full Text] [Related]
10. 'Like--but oh, how different!'.
Gaffney EF
Am J Surg Pathol; 2000 Feb; 24(2):322-3. PubMed ID: 10680910
[No Abstract] [Full Text] [Related]
11. Extraskeletal Ewing's sarcoma in a 67-year-old man.
Hanaoka N; Goto T; Kasai T; Matsuura T; Nishisho T; Enishi T; Yasui N
J Orthop Sci; 2011 Mar; 16(2):250-2. PubMed ID: 21327980
[No Abstract] [Full Text] [Related]
12. EWS-FLI1 and EWS-ERG gene fusions are associated with similar clinical phenotypes in Ewing's sarcoma.
Ginsberg JP; de Alava E; Ladanyi M; Wexler LH; Kovar H; Paulussen M; Zoubek A; Dockhorn-Dworniczak B; Juergens H; Wunder JS; Andrulis IL; Malik R; Sorensen PH; Womer RB; Barr FG
J Clin Oncol; 1999 Jun; 17(6):1809-14. PubMed ID: 10561219
[TBL] [Abstract][Full Text] [Related]
13. Linking germline and somatic variation in Ewing sarcoma.
Gomez NC; Davis IJ
Nat Genet; 2015 Sep; 47(9):964-5. PubMed ID: 26313223
[TBL] [Abstract][Full Text] [Related]
14. Signature-based small molecule screening identifies cytosine arabinoside as an EWS/FLI modulator in Ewing sarcoma.
Stegmaier K; Wong JS; Ross KN; Chow KT; Peck D; Wright RD; Lessnick SL; Kung AL; Golub TR
PLoS Med; 2007 Apr; 4(4):e122. PubMed ID: 17425403
[TBL] [Abstract][Full Text] [Related]
15. Absence of detectable EWS/FLI1 expression after therapy-induced neural differentiation in Ewing sarcoma.
Knezevich SR; Hendson G; Mathers JA; Carpenter B; Lopez-Terrada D; Brown KL; Sorensen PH
Hum Pathol; 1998 Mar; 29(3):289-94. PubMed ID: 9496833
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of HOX genes is prevalent in Ewing sarcoma and is associated with altered epigenetic regulation of developmental transcription programs.
Svoboda LK; Harris A; Bailey NJ; Schwentner R; Tomazou E; von Levetzow C; Magnuson B; Ljungman M; Kovar H; Lawlor ER
Epigenetics; 2014 Dec; 9(12):1613-25. PubMed ID: 25625846
[TBL] [Abstract][Full Text] [Related]
17. Ewing's sarcoma oncoprotein EWS-FLI1: the perfect target without a therapeutic agent.
Uren A; Toretsky JA
Future Oncol; 2005 Aug; 1(4):521-8. PubMed ID: 16556028
[TBL] [Abstract][Full Text] [Related]
18. Ewing's sarcoma: a miracle drug waiting to happen?
Longtin R
J Natl Cancer Inst; 2003 Nov; 95(21):1574-6. PubMed ID: 14600088
[No Abstract] [Full Text] [Related]
19. NR0B1 is required for the oncogenic phenotype mediated by EWS/FLI in Ewing's sarcoma.
Kinsey M; Smith R; Lessnick SL
Mol Cancer Res; 2006 Nov; 4(11):851-9. PubMed ID: 17114343
[TBL] [Abstract][Full Text] [Related]
20. Ewing's Sarcoma.
Riggi N; Suvà ML; Stamenkovic I
N Engl J Med; 2021 Jan; 384(2):154-164. PubMed ID: 33497548
[No Abstract] [Full Text] [Related]
[Next] [New Search]